C. Gómez-Aleza

Inhibition of RANK signaling as a potential immunotherapy in breast cancer

E. González-Suárez, C. Gómez-Aleza, 2021, Oncoimmunology.

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

C. Sotiriou, S. Loi, D. Larsimont, 2020, Nature Communications.

RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenografts

A. Green, F. Al-Shahrour, E. Rakha, 2021, bioRxiv.

RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

M. Serrano, G. Gómez-López, K. Troulé, 2021, Developmental cell.

RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer

A. Green, F. Al-Shahrour, E. Rakha, 2023, EMBO molecular medicine.